What is the 13F Pro Quality Score for GUTS?

13F Pro ranks FRACTYL HEALTH, INC. (GUTS) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View GUTS's current score at https://13fpro.ai/company/GUTS (free sign-up required for the full ranking).

Where does 13F Pro source GUTS data?

All FRACTYL HEALTH, INC. fundamentals and ownership data come directly from SEC EDGAR. FRACTYL HEALTH, INC. files with the SEC under CIK 1572616. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is GUTS in?

FRACTYL HEALTH, INC. (GUTS) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is GUTS research updated on 13F Pro?

GUTS's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

FRACTYL HEALTH, INC.(GUTS)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaqsmall

Institutional-grade research for retail investors

SEC EDGAR: CIK 1572616 GUTS stock profile & AI dashboard →

13F Pro Quality Score

10.0/100

Rank #2,737 of 2,777 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

7.1/100

Profitability

0.1/100

Balance Sheet

0.3/100

Earnings Quality

27.0/100

Free Cash Flow

0.1/100

Institutional Flow

86.4/100

Revenue Scale

0.2/100

Dilution Risk

0.1/100

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why GUTS Scores 10/100

exact factor attribution · 2026-03-20

GUTS's composite is driven by institutional flow, held back by revenue growth and free cash flow. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Institutional flow

+1.8 pts

86th pct

Earnings growth

-1.0 pts

30th pct

Earnings quality

-2.3 pts

27th pct

Shareholder dilution

-2.5 pts

0th pct

Capital efficiency

-5.0 pts

0th pct

Scale

-7.5 pts

0th pct

Profitability

-7.5 pts

0th pct

Free cash flow

-7.5 pts

0th pct

Revenue growth

-8.6 pts

7th pct

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

GUTS Stock Analysis & AI Quality Score

Data updated 2026-07-26

AI stock analysis and institutional research for FRACTYL HEALTH, INC. (GUTS), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores GUTS at 10.0/100 on a 32-signal composite quality model, placing it at rank #2,737 of 2,777 stocks — the bottom half of the AI-ranked universe. GUTS scores in the top quartile across institutional flow (86.4). Areas of concern include profitability (0.1) and free cash flow (0.1), which score below median versus the broader universe. Shareholder dilution risk is elevated at 0.1/100, reflecting ongoing share issuance or stock-based compensation. Top institutional holders of GUTS by reported 13-F value include Nantahala Capital Management, Catalio Capital Management, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. GUTS trades on the Nasdaq exchange and files with the SEC under CIK 1572616. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate GUTS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for FRACTYL HEALTH, INC. directly from SEC EDGAR. FRACTYL HEALTH, INC.'s 13F Pro composite quality score has ranged between 4 and 10 since 2025, currently 10.0 — an improving long-term trajectory across 25 quarterly and live scoring snapshots.

Net Income

Q2 2026

$-25.5M

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

-100.0% YoY

$0.00FY 2025

FY22 —FY23 $120.0KFY24 $93.0KFY25 $0.00

Net Income

-105.2% YoY

$-141.0MFY 2025

FY22 —FY23 $-77.1MFY24 $-68.7MFY25 $-141.0M

Operating Income

-3.5% YoY

$-96.8MFY 2025

FY22 —FY23 $-50.8MFY24 $-93.5MFY25 $-96.8M

EPS (Diluted)

-14.8% YoY

$-1.86FY 2025

FY22 —FY23 $-45.29FY24 $-1.62FY25 $-1.86

Total Assets

+12.3% YoY

$121.4MFY 2025

FY22 —FY23 $76.2MFY24 $108.1MFY25 $121.4M

Op. Cash Flow

-37.9% YoY

$-90.3MFY 2025

FY22 —FY23 $-42.8MFY24 $-65.5MFY25 $-90.3M

Free Cash Flow

-35.1% YoY

$-90.9MFY 2025

FY22 —FY23 $-43.2MFY24 $-67.3MFY25 $-90.9M

Metric	FY 2025	FY 2024	FY 2023	FY 2022
Revenue	$0.00 -100.0%	$93.0K -22.5%	$120.0K	—
Net Income	$-141.0M -105.2%	$-68.7M +10.9%	$-77.1M	—
Operating Income	$-96.8M -3.5%	$-93.5M -84.0%	$-50.8M	—
EPS (Diluted)	$-1.86 -14.8%	$-1.62 +96.4%	$-45.29	—
Total Assets	$121.4M +12.3%	$108.1M +41.8%	$76.2M	—
Operating Cash Flow	$-90.3M -37.9%	$-65.5M -53.0%	$-42.8M	—
Free Cash Flow	$-90.9M -35.1%	$-67.3M -55.8%	$-43.2M	—

Get alerted when GUTS's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for FRACTYL HEALTH, INC. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of GUTS

Nantahala Capital Management, LLC
$9.0M11,289,096 sh
Catalio Capital Management, LP
$4.9M6,168,749 sh
VANGUARD CAPITAL MANAGEMENT LLC
$4.8M6,096,926 sh
BANK OF AMERICA CORP /DE/
$4.8M6,034,147 sh
Pale Fire Capital SE
$4.0M5,003,237 sh
General Catalyst Group Management, LLC
$3.9M4,884,186 sh
Deer Management Co. LLC
$3.8M4,770,901 sh
MAVERICK CAPITAL LTD
$3.2M3,974,806 sh
M28 Capital Management LP
$1.5M1,856,117 sh
BlackRock, Inc.
$1.4M1,801,060 sh

Fund	Value	Shares
Nantahala Capital Management, LLC	$9.0M	11,289,096
Catalio Capital Management, LP	$4.9M	6,168,749
VANGUARD CAPITAL MANAGEMENT LLC	$4.8M	6,096,926
BANK OF AMERICA CORP /DE/	$4.8M	6,034,147
Pale Fire Capital SE	$4.0M	5,003,237
General Catalyst Group Management, LLC	$3.9M	4,884,186
Deer Management Co. LLC	$3.8M	4,770,901
MAVERICK CAPITAL LTD	$3.2M	3,974,806
M28 Capital Management LP	$1.5M	1,856,117
BlackRock, Inc.	$1.4M	1,801,060

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put GUTS on your watchlist

Track score changes the day FRACTYL HEALTH, INC. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is GUTS a good stock to buy?

13F Pro's AI-powered analysis of FRACTYL HEALTH, INC. (GUTS) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for GUTS are available on the GUTS stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. GUTS is classified as a small company.

Which hedge funds own GUTS?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling GUTS. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of FRACTYL HEALTH, INC.'s investment landscape.